Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer.

Ren T, Jiang B, Jin G, Li J, Dong B, Zhang J, Meng L, Wu J, Shou C.

Cancer Lett. 2008 Jun 8;264(1):83-92. doi: 10.1016/j.canlet.2008.01.028. Epub 2008 Mar 5.

PMID:
18325661
[PubMed - indexed for MEDLINE]
2.

[Production of anti-recombinant human arrest defective 1 protein (hARD1) monoclonal antibodies for assaying human breast cancer tissues].

Yu M, Wang Z, Gong J, Ma M, Jiao Y, Huang W, Lü Q, Li L, Yang H, Tan D.

Sheng Wu Gong Cheng Xue Bao. 2010 Jan;26(1):57-62. Chinese.

PMID:
20353093
[PubMed - indexed for MEDLINE]
3.

Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.

Liu C, Guo J, Qu L, Bing D, Meng L, Wu J, Shou C.

Cancer Lett. 2008 Sep 28;269(1):148-58. doi: 10.1016/j.canlet.2008.04.037. Epub 2008 Jun 30.

PMID:
18586385
[PubMed - indexed for MEDLINE]
4.

Two novel monoclonal antibodies against human CD133-2: distinct epitopes and agonist activity to enhance growth of CD133 expression cells in vitro.

Wang J, Li F, Zhang G, Chen Y, Hu Y, Chen X, Lu B, Zhang X.

Hybridoma (Larchmt). 2010 Jun;29(3):241-9. doi: 10.1089/hyb.2009.0113.

PMID:
20569000
[PubMed - indexed for MEDLINE]
5.

Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.

Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L, Xie Y, Zhang J, Chen Y, Budman DR, Shi YE.

Int J Cancer. 2007 Sep 15;121(6):1296-305.

PMID:
17534899
[PubMed - indexed for MEDLINE]
6.

Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.

Stern HM, Padilla M, Wagner K, Amler L, Ashkenazi A.

Clin Cancer Res. 2010 Mar 1;16(5):1587-96. doi: 10.1158/1078-0432.CCR-09-3108. Epub 2010 Feb 23.

PMID:
20179215
[PubMed - indexed for MEDLINE]
Free Article
7.

Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients.

Wang X, Wang S, Tang X, Zhang A, Grabinski T, Guo Z, Hudson E, Berghuis B, Webb C, Zhao P, Cao B.

J Immunol Methods. 2010 Oct 31;362(1-2):151-60. doi: 10.1016/j.jim.2010.09.026. Epub 2010 Oct 1.

PMID:
20869966
[PubMed - indexed for MEDLINE]
8.

Generation and characterization of monoclonal antibodies against tuberous sclerosis complex 2.

Malanchuk O, Palchevskyy S, Ovcharenko G, Gwalter J, Pozur V, Gout I, Filonenko V.

Hybridoma (Larchmt). 2007 Aug;26(4):259-66.

PMID:
17725389
[PubMed - indexed for MEDLINE]
9.

[hARD1 antiserum preparation and primary immunohistochemical analysis of hARD1 in tumor tissues].

Yu M, Huang C, Xiang M, Lai J, Yang H, Ma M, Tan D.

Sheng Wu Gong Cheng Xue Bao. 2008 Jul;24(7):1155-61. Chinese.

PMID:
18837388
[PubMed - indexed for MEDLINE]
10.

Specific recognition of cytosolic thymidine kinase in the human lung tumor by monoclonal antibodies raised against recombinant human thymidine kinase.

Kuroiwa N, Nakayama M, Fukuda T, Fukui H, Ohwada H, Hiwasa T, Fujimura S.

J Immunol Methods. 2001 Jul 1;253(1-2):1-11.

PMID:
11384664
[PubMed - indexed for MEDLINE]
11.

A novel monoclonal antibody specific to DIXDC1 protein.

Liu T, Wang L, Chen Q, Zheng L, Zhu H.

Hybridoma (Larchmt). 2009 Jun;28(3):183-8. doi: 10.1089/hyb.2009.0003.

PMID:
19519246
[PubMed - indexed for MEDLINE]
12.

Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.

Li J, Guo K, Koh VW, Tang JP, Gan BQ, Shi H, Li HX, Zeng Q.

Clin Cancer Res. 2005 Mar 15;11(6):2195-204.

PMID:
15788667
[PubMed - indexed for MEDLINE]
Free Article
13.

Generation and characterization of a panel of monoclonal antibodies specific for human fibroblast growth factor receptor 4 (FGFR4).

Chen C, Patel S, Corisdeo S, Liu X, Micolochick H, Xue J, Yang Q, Lei Y, Wang B, Soltis D.

Hybridoma (Larchmt). 2005 Jun;24(3):152-9.

PMID:
15943563
[PubMed - indexed for MEDLINE]
14.

Production of a monoclonal antibody against the hRRM2 subunit of ribonucleotide reductase and immunohistochemistry study of human cancer tissues.

Zhou B, Phan V, Liu X, Juhasz A, Chu PG, Yen Y.

Hybridoma (Larchmt). 2006 Oct;25(5):264-70.

PMID:
17044781
[PubMed - indexed for MEDLINE]
15.

Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.

Kim KH, Shim JH, Seo EH, Cho MC, Kang JW, Kim SH, Yu DY, Song EY, Lee HG, Sohn JH, Kim J, Dinarello CA, Yoon DY.

J Immunol Methods. 2008 Apr 20;333(1-2):38-50. doi: 10.1016/j.jim.2007.12.017. Epub 2008 Jan 28.

PMID:
18252253
[PubMed - indexed for MEDLINE]
16.

Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.

Mayevska O, Shuvayeva H, Igumentseva N, Havrylov S, Basaraba O, Bobak Y, Barska M, Volod'ko N, Baranska J, Buchman V, Drobot L.

Exp Oncol. 2006 Dec;28(4):275-81.

PMID:
17285110
[PubMed - indexed for MEDLINE]
17.

Ornithine decarboxylase gene is overexpressed in colorectal carcinoma.

Hu HY, Liu XX, Jiang CY, Lu Y, Liu SL, Bian JF, Wang XM, Geng Z, Zhang Y, Zhang B.

World J Gastroenterol. 2005 Apr 21;11(15):2244-8.

PMID:
15818733
[PubMed - indexed for MEDLINE]
Free Article
18.

Preparation and characterization of monoclonal antibody against translationally controlled tumor protein.

Qiang M, Fenfang W, Yan G, Wen S, Maoliang H, Yingsong W, Weiwen X, Ming L.

Hybridoma (Larchmt). 2011 Feb;30(1):81-5. doi: 10.1089/hyb.2010.0075.

PMID:
21466289
[PubMed - indexed for MEDLINE]
19.

Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.

Chang CC, Lin MT, Lin BR, Jeng YM, Chen ST, Chu CY, Chen RJ, Chang KJ, Yang PC, Kuo ML.

J Natl Cancer Inst. 2006 Jul 19;98(14):984-95.

PMID:
16849681
[PubMed - indexed for MEDLINE]
Free Article
20.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.

PMID:
19535783
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk